Druggists Companies in Malaysia
The Malaysian government has identified the pharmaceutical and medical device industries as key growth areas in the country’s economy. As a result, a number of incentives have been put in place to attract foreign investment in these sectors.
One of the most attractive incentives for foreign investors is the Malaysian Investment Development Authority’s (MIDA) 100% foreign equity ownership policy for manufacturing projects in the pharmaceutical and medical device industries. This policy allows foreign companies to fully own their manufacturing operations in Malaysia, giving them greater control over their business.
In addition, the Malaysian government has also put in place a number of tax incentives for companies operating in the pharmaceutical and medical device industries. These incentives include a 10-year income tax exemption for new manufacturing projects and a 5-year income tax exemption for expanding existing manufacturing projects.
The Malaysian government’s efforts to attract foreign investment in the pharmaceutical and medical device industries are paying off. A number of major international companies have already set up operations in Malaysia, including Pfizer, GlaxoSmithKline, and Johnson & Johnson.
One of the most attractive incentives for foreign investors is the Malaysian Investment Development Authority’s (MIDA) 100% foreign equity ownership policy for manufacturing projects in the pharmaceutical and medical device industries. This policy allows foreign companies to fully own their manufacturing operations in Malaysia, giving them greater control over their business.
In addition, the Malaysian government has also put in place a number of tax incentives for companies operating in the pharmaceutical and medical device industries. These incentives include a 10-year income tax exemption for new manufacturing projects and a 5-year income tax exemption for expanding existing manufacturing projects.
The Malaysian government’s efforts to attract foreign investment in the pharmaceutical and medical device industries are paying off. A number of major international companies have already set up operations in Malaysia, including Pfizer, GlaxoSmithKline, and Johnson & Johnson.
UIRTIUS SPLASH SDN BHD - 1284848-D
JADEK MEDICA SDN BHD - 1265721-A
MEDINI ORTHOPAEDIC CENTRE SDN BHD - 1110200-D
EDAR SUCI SDN BHD - 1075713-M
VHIYO VEDIC VENTURES SDN BHD - 1047471-D Profile
PHARMIRAGE SDN BHD - 1021476-X
EAGLE CLIFFE (M) SDN BHD - 965150-P Profile
LR COATING SDN BHD - 961852-K
NELRENE HOMEOPATHY CENTRE SDN BHD - 932633-A
HARSHIV SDN BHD - 911929-M
PAGALAVAN HEALTHCARE SDN BHD - 889720-D
PERLING DENTAL SURGERY SDN BHD - 868428-V
DMIS TRADING SDN BHD - 864873-T
ZEISS CHEMICAL SDN BHD - 837977-H
BIOFRESH GROWTH SDN BHD - 803363-X
PEARL LIFE SDN BHD - 800365-X
MAG ORTHOCARE SDN BHD - 797737-M
COFFEE OMEGA (M) SDN BHD - 787284-D
POLIKLINIK CHU SDN BHD - 716494-H Profile
SHUKOR ORTHOPAEDIC SDN BHD - 683245-U
MEDUSA BIOTECH CORPORATION SDN BHD - 668389-D
LANCASTER MEDICAL GROUP SDN BHD - 619467-A
TAI SEONG GINSENG HALL SDN BHD - 612997-U
WHOLE CARE PHARMACY SDN BHD - 605161-U
TEGUH PHARMA (M) SDN BHD - 548744-H Profile
MEDAN TERBAIK SDN BHD - 504822-A
EQUEST CLASSIC (M) SDN BHD - 457320-K
ANW CHEMICALS SDN BHD - 428300-H
BAOAN SDN BHD - 239076-P
DAYA PHARMA SDN BHD - 180412-K
INTELMED (M) SDN BHD - 173424-T
POLYSCIENTIFIC ENTERPRISE SDN BHD - 152064-D Profile
FAMEDIC POLYKLINIK SDN BHD - 149521-V
BABYCARE PHARMACY SDN BHD - 115319-V
HIGH MEAN (EM) SDN BHD - 64848-T
EISAI (MALAYSIA) SDN BHD - 18039-D